These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4391098)
1. Controlled interviews using drugs. Smith BM; Hain JD; Stevenson I Arch Gen Psychiatry; 1970 Jan; 22(1):2-10. PubMed ID: 4391098 [No Abstract] [Full Text] [Related]
2. Controlled interviews using drugs. II. Comparisons between restricted and freer conditions. Buckman J; Hain JD; Smith BM; Stevenson I Arch Gen Psychiatry; 1973 Nov; 29(5):623-7. PubMed ID: 4149325 [No Abstract] [Full Text] [Related]
3. Emotional expression, memory and feelings during and after interviews with drugs. Smith BM; Hain JD; Stevenson I Behav Neuropsychiatry; 1969 Jun; 1(3):10-4. PubMed ID: 4394675 [No Abstract] [Full Text] [Related]
4. The use of drugs in psychiatric interviews: some interpretations based on controlled experiments. Stevenson I; Buckman J; Smith BM; Hain JD Am J Psychiatry; 1974 Jun; 131(6):707-10. PubMed ID: 4151258 [No Abstract] [Full Text] [Related]
9. Barbiturate-assisted interviews in modern clinical practice. Patrick M; Howells R Psychol Med; 1990 Nov; 20(4):763-5. PubMed ID: 2284383 [No Abstract] [Full Text] [Related]
10. Anxiety and beta-adrenergic blockade. Stone WN; Gleser GC; Gottschalk LA Arch Gen Psychiatry; 1973 Nov; 29(5):620-2. PubMed ID: 4589810 [No Abstract] [Full Text] [Related]
11. The amobarbital interview revisited: a review of the literature since 1966. Kavirajan H Harv Rev Psychiatry; 1999; 7(3):153-65. PubMed ID: 10483934 [TBL] [Abstract][Full Text] [Related]
12. The place of barbiturates in psychiatric treatment. Meares R Med J Aust; 1970 Jun; 1(24):1207-9. PubMed ID: 5451396 [No Abstract] [Full Text] [Related]
13. Effectiveness and processes of interviewing with drugs. Hain JD; Smith BM; Stevenson I J Psychiatr Res; 1966 Nov; 4(2):95-106. PubMed ID: 20034162 [TBL] [Abstract][Full Text] [Related]
14. Methodology for the clinical investigation of psychotherapeutic drugs. Hollister LE; Overall JE J New Drugs; 1965; 5(5):286-93. PubMed ID: 5329632 [No Abstract] [Full Text] [Related]
15. The psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents. Resnich O Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:30-6. PubMed ID: 4873471 [No Abstract] [Full Text] [Related]
16. Effects of placebo, Dexamyl, and Lucofen on moods, emotions, and motivations. Cameron JS; Specht PG; Wendt GR J Psychol; 1967 Jul; 66(2):199-209. PubMed ID: 4864827 [No Abstract] [Full Text] [Related]
17. The sodium amytal interview as a therapeutic modality. Marcos LR; Trujillo M Curr Psychiatr Ther; 1978; 18():129-36. PubMed ID: 753580 [No Abstract] [Full Text] [Related]
18. Abreaction before ECT. Howells R; Patrick M Br J Psychiatry; 1992 Jan; 160():132. PubMed ID: 1544003 [No Abstract] [Full Text] [Related]
19. Overview: clinical applications of the Amytal interview in psychiatric emergency settings. Perry JC; Jacobs D Am J Psychiatry; 1982 May; 139(5):552-9. PubMed ID: 7072839 [TBL] [Abstract][Full Text] [Related]
20. Appendix to: the psychoactive properties of diphenylhydantoin: experiences with prisoners and juvenile delinquents. Resnick O Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:37-48. PubMed ID: 4873472 [No Abstract] [Full Text] [Related] [Next] [New Search]